Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

51 results about "Alanine racemase" patented technology

In enzymology, an alanine racemase (EC 5.1.1.1) is an enzyme that catalyzes the chemical reaction L-alanine ⇌ D-alanine Hence, this enzyme has one substrate, L-alanine, and one product, D-alanine. This enzyme belongs to the family of isomerases, specifically those racemases and epimerases acting on amino acids and derivatives. The systematic name of this enzyme class is alanine racemase. This enzyme is also called L-alanine racemase.

XZ-A26 bacterial strain for producing L-alanine with high yield as well as construction method and application of XZ-A26 bacterial strain

The invention discloses an XZ-A26 bacterial strain for producing L-alanine with high yield, which has a preservation number of CGMCC (China General Microbiological Culture Collection Center) No.4036 and has the capacity of generating high-concentration L-alanine through fermentation. The XZ-A26 bacterial strain is constructed by the steps of: integrating an L-alanine dehydrogenase gene on thermophilic fatty bacillus chromosome on lactic dehydrogenase position on an escherichia coli ATCC8739 chromosome, then sequentially knocking out a pyruvate formate lyase gene, an alcohol dehydrogenase gene, an acetokinase gene, a fumaric acid reductase gene and an alanine racemase gene of the escherichia coli chromosome, and then carrying out continuous cell culture in a fermenting tank for obtaining agenetic engineering strain. The invention also relates to a construction method of the XZ-A26 bacterial strain and an application of the XZ-A26 bacterial strain in preparation of the L-alanine. According to the invention, the escherichia coli with the preservation number of CGMCC No.4036 for generating the high-concentration L-alanine through fermentation can be constructed by using a metabolic engineering method, and the yield of the L-alanine generated by using the XZ-A26 bacterial strain reaches up to 115g / L. The XZ-A26 bacterial strain is suitable for industrially producing the L-alanine.
Owner:ANHUI HUAHENG BIOTECH

Engineering bacteria producing DL-alanine and method of producing DL-alanine by using engineering bacteria

The invention discloses a strain of engineering bacteria producing DL-alanine. Lactic dehydrogenase, pyruvate formate lyase, alcohol dehydrogenase, acetic acid kinase, fumaric acid reductase, alanine racemase and methyl glyoxal synthetase of the strain of engineering bacteria producing the DL-alanine are inactivated; and exogenous L-alanine dehydrogenase gene and alanine racemase gene are integrated on the chromosome of the engineering bacteria. According to the invention, pyroracemic acid, an intermediate product of the glycolysis is converted to L-alanine by integrating the exogenous L-alanine dehydrogenase gene into the chromosome of the engineering bacteria; and an exogenous alanine racemase gene is further integrated into the chromosome, and part of the L-alanine is converted into D-alanine. Then producing the DL-alanine from raw material sugar in one step is realized, the production period of the DL-alanine is decreased and the productivity of the DL-alanine is enhanced.
Owner:ANHUI HUAHENG BIOTECH

Recombinant bacillus subtilis for expressing cellobiose-2-epimerase based on D-alanine defective screening, and construction method of recombinant bacillus subtilis

The invention relates to a recombinant bacillus subtilis for expressing cellobiose-2-epimerase based on a D-alanine defective screening marker, as well as a construction method and an application of the recombinant bacillus subtilis, belonging to the technical field of genetic engineering of enzyme. According to the invention, bacillus subtilis 1A751 is taken as an original strain, D-alanine racemase genes (dal) on the chromosome of the bacillus subtilis 1A751 strain are knocked out, so that D-alanine defective bacillus subtilis 1A751 (dal<->) is obtained; by taking cellobiose-2-epimerase (CE enzyme) from thermoanaerobacter tengcongensis as a parent, fusing a P43 promoter on the upstream of the parent to establish P43-TsCE, establishing P43-TsCE to plasmid pUB110 to obtain pUB-P43-TsCE, and replacing antibiotics resistance genes kanamycin and bleomycin on the plasmid pUB-P43-TsCE with (dal), so as to construct pUB-P43-TsCE-dal; and transforming pUB-P43-TsCE-dal into host 1A751 (dal<->), and thus obtaining the recombinant bacillus subtilis for expressing cellobiose-2-epimerase, wherein the preservation number is CCTCC NO: M 2015582. The total enzyme activity of fermentation liquor reaches 7U / mL, and thus the recombinant bacillus subtilis has an important industrial application value.
Owner:JIANGNAN UNIV

Alanine dehydrogenase mutant and application thereof

The invention discloses an alanine dehydrogenase mutant and application thereof, and belongs to the technical field of biological engineering. According to the alanine dehydrogenase mutant, archaeoglobus fulgidus derived alanine dehydrogenase is modified through protein engineering; an optimal enzyme-activity temperature of the alanine dehydrogenase is decreased from 82 DEG C to 50 DEG C; a key gene on a synthetic competitive route of L-alanine is cancelled in bacillus coli K12; the generation of by-products is reduced; an alaD gene and an alanine racemase dadX gene for coding the L-alanine dehydrogenase in a recombinant strain are replaced with modified archaeoglobus fulgidus derived alanine dehydrogenase genes; the two-stage fermentation is carried out by utilizing the recombinant strain; the fermentation is carried out for 42h; a yield of the L-alanine reaches 153.9g / L, and a sugar-acid conversion ratio is 81.0 percent.
Owner:金华利家园生物工程有限公司 +1

Method for removing alanine in reaction system for preparing neutral amino acid

The invention provides a method for removing alanine in a reaction system for preparing neutral amino acid, wherein the reaction system for preparing the neutral amino acid is a reaction system adopting a transaminase method or a fermentation method to prepare the neutral amino acid. The method provided by the invention is as follows: alanine racemase and a catalyst capable of specially catalyzing single chiral amino acid for further reaction are added into the reaction system, thus specially removing the alanine in the reaction system. The method can specially remove the alanine in conversion liquid or fermentation liquid, thus simplifying the separation and purification and refining the technique of the neutral target amino acid.
Owner:SHANGHAI RES & DEV CENT OF INDAL BIOTECH +1

Method for preparing L-tertiary leucine compound by two enzyme system

InactiveCN101845476ASplit fitEasy to operateFermentationAlkaneHalogen
The invention relates to a method for preparing a chiral compound based on splitting by adopting a biological enzyme preparation, in particular to a method for preparing an L-tertiary leucine compound by a two enzyme system. The method prepares the chiral L-tertiary leucine compound of the formula III by using the reaction of an N-acylating tertiary leucine compound of the formula II in water or a buffer solvent at 15 to 60 DEG C in the presence of the two enzyme system. The biological enzyme is a mixed enzyme of an acylating amino acid racemase (alanine racemase) and a hydrolase; and the preparation reaction equation is as follows, wherein X is any group of OH, NH2, NR1R2 and OR3 (wherein R1, R2, R3 are a C1-C5 straight chain, a branch chain and a one, two or three-halogen substituted alkane respectively). The invention can be implemented at room temperature and ensures simple operation and no pollution, while remarkably lowering the production cost.
Owner:ZHEJIANG UNIV

Construction method and fermenting method of antibiotic-resistance-free recombinant bacillus subtilis for expressing glutamate decarboxylase

The invention relates to a construction method and a fermenting method of antibiotic-resistance-free recombinant bacillus subtilis for expressing glutamate decarboxylase and belongs to the technical field of bioengineering. The construction method includes taking bacillus subtilis WB600 as an original strain, and knocking out a D-alanine racemase gene on a chromosome of the bacillus subtilis WB600 so as to obtain D-alanine deficient WB600 (dal); fusing an optimized gad gene with an antibiotic-resistance-free expression vector pUB110 (a antibiotics resistance gene is replaced by the D-alanine racemase gene) through an overlap extension PCR technology to obtain a polymer, transforming the polymer into competence of the bacillus subtilis WB600, and enabling the polymer to recombine in a host so as to obtain a recombinant plasmid Pub-HpaII-P43-gad-dal, which is named as bacillus subtilis SK44.001 with the preservation number being CCTCC NO:M 2016774. The fermentation liquor enzyme activity of the antibiotic-resistance-free recombinant bacillus subtilis can be up to 8.6 U / mL, and accordingly the antibiotic-resistance-free recombinant bacillus subtilis has significant industrial application value.
Owner:JIANGNAN UNIV

Alanine racemase chiral binaphthol derivative with powerful hydrogen bond donor, and optical resolution and optical transformation methods using the same

Disclosed is an alanine racemase chiral binaphthol derivative having the ability to recognize amino alcohols selectively on the basis of chirality and transform amino acids from an L-form into a D-form. Methods for the optical resolution of amino acid or amino alcohol and for the optical transformation of D- and L-forms of amino acids using the binaphthol derivative are also provided.
Owner:EWHA UNIV IND COLLABORATION FOUND +1

Strain for producing high-yield DL-alanine and application thereof

ActiveCN103275918AHigh alanine racemase activityBacteriaMicroorganism based processesEscherichia coliAlanine racemase
The invention provides a strain for producing high-yield DL-alanine and an application thereof, and particularly provides an engineering strain for producing D-alanine racemase. The strain is esherichia coli and carries an expression vector for expressing Bacillus subtilis D-alanine racemase. The expression strain can be effectively used for producing the DL-alanine at a low cost, and has a higher application value.
Owner:ANHUI HUAHENG BIOTECH

Construction method of recombinant Bacillus subtilis expressing d-psicose 3-epimerase based on d-alanine-deficient selection marker

The invention discloses a method for constructing a recombinant Bacillus subtilis expressing D-psicose 3-epimerase based on a D-alanine-deficient selection marker, belonging to the technical field of enzyme gene engineering. Taking Bacillus subtilis 1A751 as the starting strain, knocking out the D-alanine racemase gene (dal) on its chromosome to obtain D-alanine-deficient 1A751 (dal-); the DPE of Clostridium ATCC 35704 The enzyme gene was used as a parent, and its upstream fusion P43 promoter was constructed into P43‑DPE, which was constructed into plasmid pUB110 (NCBI‑Gene ID: 9507338) to obtain pUB‑P43‑DPE, and the antibiotic resistance on pUB‑P43‑DPE The sex genes Kan and Blm were replaced by dal to construct pUB-P43-DPE-dal; then transformed into 1A751(dal-) to obtain recombinant Bacillus subtilis 1A751-pUB-P43-DPE-dal, which was named as Bacillus subtilis ( Bacillus subtilis) SK38.001, deposit number CCTCC NO:M 2015257. The total enzyme activity of its fermented liquid reaches 16U / mL, which has important industrial application value.
Owner:山东星光首创生物科技有限公司

Method for producing optically pure L-alanine by one pseudomonas and two enzymes

The invention discloses a method for producing optically pure L-alanine by one pseudomonad and two enzymes, comprising the following steps of: seed culture in a shake flask and fermentation; utilizing pseudomonas to generate two enzymes: an L-aspartase and an L-aspartic acid-Beta-decarboxylase; taking a fumaric acid ammonium salt as a substrate to directly generate the L-alanine; and obtaining the optically pure L-alanine by changing the system reaction condition and adding the L-alanine racemase inhibitor. The method reduces the whole production link and equipment investment for the L-alanine, lightens the environmental pollution, has high yield of L-alanine, has the optical purity of more than or equal to 99.99% and meets the requirements of factories that have special requirements on the L-alanine with high optical purity.
Owner:ANHUI HUAHENG BIOTECH

Microfluidic Device Screening Method

The invention provides methods of screening a microbial host cell for a property of interest in a microfluidic device, the method comprising the steps of: a) transforming a d-alanine racemase-deficient microbial host cell with a polynucleotide construct comprising: i) one or more polynucleotide region providing the property of interest when present in the host cell, and ii) at least one polynucleotide region complementing the d-alanine racemase deficiency when present in the host cell; and b) screening the transformed host cell for the property of interest in the microfluidic device in the absence of externally provided d-alanine.
Owner:NOVOZYMES AS

Trigenic coexpression vector for synthesizing DL-alanine and application

The invention discloses construction of a trigenic coexpression vector for synthesizing DL-alanine and application. The construction is characterized in that encoding alanine dehydrogenase (ald), alanine racemase (alr) and glucose dehydrogenase (gdh) genes in pseud bacillus firmus are connected in series and then are inserted into reconstructed plasmid pET-22bNS, so as to construct the trigenic coexpression vector pET-22bNS-G / A / A. After constructed trigenic coexpression vector is transformed into escherichia coli BL21(DE3) and is subjected to whole-cell catalytic reaction for 3h through recombination strain, the output of L-alanine and the output of D-alanine are the highest and are correspondingly 7.0mg / mL and 6.5mg / mL, and the maximum synthesizing efficiency of L-alanine and the maximumsynthesizing efficiency of D-alanine are correspondingly 56.4mg / mL / d and 51.9mg / mL / d. The constructed trigenic coexpression vector has a capacity of efficiently synthesizing DL-alanine and is high inapplication value.
Owner:HEBEI NORMAL UNIV

alr (alanine racemase)-deficient lactobacillus plantarum NC8

The invention discloses alr (alanine racemase)-deficient lactobacillus plantarum NC8 and an alr-marked expression vector pCJ2. The alr-deficient lactobacillus plantarum NC8 is alr-gene-deficient lactobacillus plantarum NC8 obtained after transfecting an alr-deficient suicide plasmid pNZ5319-Deltaalr with lactobacillus plantarum NC8, and in addition, the alr-marked expression vector pCJ2 is constructed. A food-grade lactobacillus expression system is implemented, and safety and reliability are achieved.
Owner:JILIN AGRICULTURAL UNIV

Method for preparing DL-alanine and D-alanine

The invention discloses a method for preparing DL-alanine and D-alanine. Fumaric acid and ammonia react through aspartase in a coupling reactor to synthesize L-aspartic acid; the synthesized L-aspartic acid reacts with L-aspartate dacarboxylase to obtain L-alanine; L-alanine undergoes racemization through alanine racemase to obtain DL-alanine; and DL-alanine concentrated mother liquor undergoes splitting through L-alanine aminotransferase in a fermentation cylinder so as to obtain D-alanine. Production of DL-alanine or D-alanine requires no extraction of intermediate products. The final product is obtained directly by one step. Thus, usage of sulfuric acid required for electroextraction of L-aspartic acid and the like, labor for each extraction process, energy consumption and production loss such as dissipation in actual production process are reduced. Meanwhile, DL-alanine mother liquor is comprehensively utilized for production of D-alanine, and overall yield and economic benefit are raised.
Owner:宜兴市前成生物有限公司

Cryoprotectant and application thereof in cryopreservation of umbilical cord mesenchymal stem cells

The invention discloses a cryoprotectant. The cryoprotectant comprises the following components: dimethyl sulfoxide in volume percentage of 1-5%, 20-80mmol / L trehalose, 5-15ug / mL catalase, 10-40ug / mLZ-valine-alanine racemase-ASP (methyl ester)-methyl fluoride ketone, 0.1-3ug / mL insulin and 0.01-10mg / L selenium. The cryoprotectant disclosed by the invention is serum-free, so that the pollution ofpathogenic bacteria can be avoided; the content of dimethyl sulfoxide (DMSO) is less, so that the cytotoxicity is reduced; the cryoprotectant disclosed by the invention is prepared from pure chemicalsubstances, the components are stable and the batch-to-batch stability is high; after the cells cryopreserved with the cryoprotectant disclosed by the invention revive, the cell viability is obviouslyenhanced. The invention also discloses an application of the cryoprotectant in cryopreservation of umbilical cord mesenchymal stem cells. The invention also discloses a cryopreservation method of theumbilical cord mesenchymal stem cells.
Owner:GUANGZHOU RAINHOME PHARM&TECH CO LTD

Animal waste metagenome-derived alanine racemase as well as preparation and application thereof

The invention discloses animal waste metagenome-derived alanine racemase as well as preparation and application thereof. The amino acid sequence is shown as SEQ ID NO.2, and after the alanine racemase is treated by a buffer solution with the pH value of 9.0-12.0 for 1 hour, the residual enzyme activity is 90% or above; when the alanine racemase is tolerant for 1 hour under the conditions of 30 DEG C, 37 DEG C, 40 DEG C and 45 DEG C, 90% of enzyme activity is still kept; the optimal cofactor concentration is 10 mumol / L, and 77% of relative activity is still maintained after the reaction is carried out for 10 min under the condition that no exogenous cofactor is added. Km and Vmax of the enzyme are 14.81 mmol / L and 89.06 mumol / L / min respectively under the conditions that the pH is 12.0 and the temperature is 40 DEG C NaCl, and the enzyme has thermal stability and alkali resistance, still has higher activity without adding exogenous cofactors, and has potential application value in the aspects of synthesizing D-amino acid by an enzyme method and screening novel antibacterial drugs.
Owner:YUNNAN NORMAL UNIV

Antituberculosis drug and screening method thereof

ActiveCN104945329AGood anti-tuberculosis activityBroad spectrum anti-tuberculosisAntibacterial agentsOrganic active ingredientsAntituberculosis drugAlanine racemase
The invention relates to an antituberculosis drug disclosed as Formula I and a screening method thereof. An antituberculosis drug screening model is established by using alanine racemase as a target spot; and the model is utilized to screen out the antituberculosis drug with application prospects. The invention also relates to a composition containing the antituberculosis drug disclosed as Formula I and application of the antituberculosis drug disclosed as Formula I in preparing drugs for preventing or treating tuberculosis.
Owner:MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI

Method for preparing DL-alanine with fumaric acid as raw material through multi-enzyme coupling

The invention belongs to the technical field of biology and particularly relates to a method for preparing DL-alanine with fumaric acid as raw material through multi-enzyme coupling. The preparation method uses the fumaric acid as raw materials, bacteria cells containing aspartase, aspartic acid-beta-decarboxylase and alanine racemase or crude enzyme of the aspartase, the aspartic acid-beta-decarboxylase and the alanine racemase is mixed with a fumaric acid water solution of a certain concentration, enzymatic reaction is carried out at the temperature of 25-55 DEG C, under the pH 6-8, converted products are separated though an isoelectric point crystallization method or a method combining isoelectric point crystallization and ion exchange resin, and high-purity DL-alanine is obtained. According to the method, the DL-alanine is prepared efficiently by adopting the multi-enzyme coupling technology, the method has the advantages of being wide in raw material source, simple in operation of production process, short in enzymatic conversion time, low in production cost and the like.
Owner:NANJING UNIV

Identification and characterization of novel proline racemases and hydroxyproline-2-epimerases, uses thereof, and methods of identifying proline racemases and hydroxyproline-2-epimerases

InactiveUS20080138352A1Preventing mitogen-induced proliferationSugar derivativesBacteriaHydroxyprolineImmune complex deposition
This invention provides identification and characterization of racemases and epimerases and definition of protein signatures of those racemases and epimerases. This invention also provides identification of nucleic acid molecules encoding a peptide consisting of a motif characteristic of the protein signatures, and to the peptides consisting of these motifs. Antibodies specific for the peptides and to immune complexes of these antibodies with the peptides are also provided. Further, the invention relates to methods and kits for detecting racemases and epimerases using the nucleic acid molecules of the invention, as well as the peptides consisting of the motifs and antibodies to these peptides.
Owner:INST PASTEUR

Use of alanine racemase genes to confer nematode resistance to plants

InactiveCN101605903AImprove nematode resistanceClimate change adaptationIsomerasesNucleotideNematode
The invention provides alanine racemase encoding polynucleotides, which are capable of conferring increased nematode resistance in a plant. Specifically, the invention relates to methods of producing transgenic plants with increased nematode resistance, expression vectors comprising polynucleotides encoding alanine racemase, and transgenic plants and seeds generated thereof.
Owner:BASF PLANT SCI GMBH

Method for preparing D-alanine by microbial fermentation method

The invention belongs to the technical field of microbial fermentation, and particularly relates to a method for preparing D-alanine by a microbial fermentation method. The method comprises the following steps: firstly, constructing a genetically engineered bacterium for producing D-alanine, taking corynebacterium glutamicum ATCC 13032 as a starting strain of the genetically engineered bacterium, and knocking out an alanine racemase gene alr and L-alanine transaminase alaT; allowing meso-diaminopimelate dehydrogenase coding gene to be subjected to overexpression; knocking out an iolR repressor protein gene and simultaneously performing genome integration expression on a glucokinase gene glk1; and integrating edd and eda genes from Escherichia coli to obtain the gene. The strain uses glucose as a substrate to produce D-type amino acid through a direct fermentation method, the cost is low, the technology is simple, and the yield of D-alanine in a 5L fermentation tank can reach 50-60g / L. Besides, efficient synthesis of the D-type amino acid by a fermentation method belongs to creative research, and by means of the method, the fermentation method can be infinitely expanded, and various D-type amino acids can be efficiently synthesized at low cost.
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY

High-yield dl-alanine production strain and its application

ActiveCN103275918BHigh alanine racemase activityBacteriaMicroorganism based processesEscherichia coliAlanine racemase
The invention provides a strain for producing high-yield DL-alanine and an application thereof, and particularly provides an engineering strain for producing D-alanine racemase. The strain is esherichia coli and carries an expression vector for expressing Bacillus subtilis D-alanine racemase. The expression strain can be effectively used for producing the DL-alanine at a low cost, and has a higher application value.
Owner:ANHUI HUAHENG BIOTECH

Method for synthesizing D-biphenyl alanine

The invention provides a method for synthesizing D-biphenyl alanine. The method comprises the following steps: 1) adding a solvent to a reaction kettle; during stirring, sequentially adding diethyl acetamidomalonate, metallic sodium and 4-bromomethyl biphenyl; after conducting a reaction, reacting a condensation product, which is obtained through cooling crystallization, and hydrochloric acid while conducting stirring, and conducting cooling crystallization so as to obtain N-acetyl-DL-biphenyl alanine; and 2) dissolving the N-acetyl-DL-biphenyl alanine in water; adjusting pH to 6.5-8.0 by virtue of ammonia water; adding catalyzing enzymes; and after a reaction, conducting centrifuging, rinsing with water and drying so as to obtain the D-biphenyl alanine, wherein the added catalyzing enzymes include L-aminoacylase and L-alanine racemase, and the total addition of the catalyzing enzymes is 0.1-0.15% of the mass of the N-acetyl-DL-biphenyl alanine. The method provided by the invention has the advantages that the method has fewer steps, and the method is mild in reaction, free from high temperature and high pressure, highly environment-friendly, high in yield and the like.
Owner:NANJING REDWOOD FINE CHEM CO LTD

Genetic engineering bacteria containing L-alanine racemase genes and application of genetic engineering bacteria

The invention discloses genetic engineering bacteria containing L-alanine racemase genes and application of genetic engineering bacteria; the bacterial strain comprises a nucleotide sequence expressed by SEQ ID NO: 1. The genetic engineering bacteria disclosed by the invention can produce DL-alanine through racemizing L-alanine and is characterized by little dosage, short reaction time and multi-batch reutilization; by adoption of the genetic engineering bacteria of The invention, conversation rate in a racemizing procedure reaches to more than 99.0%; product purity reaches to more than 99.5%; and the genetic engineering bacteria disclosed by The invention has good industrialization prospect.
Owner:NANJING TECH UNIV

Use of Alanine Racemase Genes to Confer Nematode Resistance to Plants

The invention provides alanine racemase encoding polynucleotides, which are capable of conferring increased nematode resistance in a plant. Specifically, the invention relates to methods of producing transgenic plants with increased nematode resistance, expression vectors comprising polynucleotides encoding alanine racemase, and transgenic plants and seeds generated thereof.
Owner:HILL STEVE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products